Insider Selling: Maximus, Inc. (NYSE:MMS) Director Sells 2,439 Shares of Stock

Maximus, Inc. (NYSE:MMS - Get Free Report) Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Maximus Stock Down 0.1 %

Shares of NYSE MMS traded down $0.09 during mid-day trading on Friday, hitting $67.12. 1,944,363 shares of the stock traded hands, compared to its average volume of 490,869. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock has a fifty day moving average price of $71.07 and a 200-day moving average price of $78.55. The company has a market cap of $3.80 billion, a price-to-earnings ratio of 14.43 and a beta of 0.71. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Remove Ads

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.79%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Institutional Trading of Maximus

Several institutional investors and hedge funds have recently added to or reduced their stakes in MMS. Nordea Investment Management AB bought a new stake in shares of Maximus in the 4th quarter worth about $4,618,000. Fort Washington Investment Advisors Inc. OH lifted its stake in Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after purchasing an additional 83,390 shares during the last quarter. IFP Advisors Inc lifted its stake in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after acquiring an additional 302 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Maximus during the fourth quarter valued at $1,113,000. Finally, Charles Schwab Investment Management Inc. grew its stake in Maximus by 12.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider's stock worth $86,552,000 after acquiring an additional 102,350 shares in the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.